the early phase was characterized by a rapid transient pulmonary arterial constrictive response that was dose dependent , accompanied by a delayed transient increase in lung-lymph flow ( p less than 0.05 ) , a significant ( p less than 0.01 ) decrease in arterial blood o2 tension and an increase ( p less than 0.05 ) in lung-lymph protein clearance .
C0034052
pulmonary arterial
C0024109
lung